Details for New Drug Application (NDA): 217766

NDA 217766 describes VASOPRESSIN IN SODIUM CHLORIDE 0.9%, which is a drug marketed by Baxter Hlthcare Corp and Long Grove Pharms and is included in two NDAs. It is available from two suppliers. Additional details are available on the VASOPRESSIN IN SODIUM CHLORIDE 0.9% profile page.

The generic ingredient in VASOPRESSIN IN SODIUM CHLORIDE 0.9% is vasopressin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.

Summary for 217766

Tradename:	VASOPRESSIN IN SODIUM CHLORIDE 0.9%
Applicant:	Long Grove Pharms
Ingredient:	vasopressin
Patents:	0

Pharmacology for NDA: 217766

Physiological Effect

Decreased Diuresis Vasoconstriction

Suppliers and Packaging for NDA: 217766

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VASOPRESSIN IN SODIUM CHLORIDE 0.9%	vasopressin	SOLUTION;INTRAVENOUS	217766	NDA	Long Grove Pharmaceuticals, LLC	81298-8550	81298-8550-3	10 VIAL, SINGLE-DOSE in 1 CARTON (81298-8550-3) / 50 mL in 1 VIAL, SINGLE-DOSE (81298-8550-1)
VASOPRESSIN IN SODIUM CHLORIDE 0.9%	vasopressin	SOLUTION;INTRAVENOUS	217766	NDA	Long Grove Pharmaceuticals, LLC	81298-8552	81298-8552-3	10 VIAL, SINGLE-DOSE in 1 CARTON (81298-8552-3) / 100 mL in 1 VIAL, SINGLE-DOSE (81298-8552-1)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	20UNITS/100ML (0.2UNITS/ML)
Approval Date:	Jul 11, 2024	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	40UNITS/100ML (0.4UNITS/ML)
Approval Date:	Jul 11, 2024	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	50UNITS/50ML (1UNIT/ML)
Approval Date:	Jul 11, 2024	TE:		RLD:	Yes

Complete Access Available with Subscription